Estimate Recalculated Nov 7, 2024 04:47PM EST
Shawn Cross does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Applied Molecular Transport Inc., BioPlus Acquisition Corp., GT Biopharma, Inc., and Cyclo Therapeutics, Inc..
Shawn Cross's CIK is 0001734779
2021 was Shawn Cross's most active year for acquiring shares with 4 total transactions. Shawn Cross's most active month to acquire stocks was the month of July. 2023 was Shawn Cross's most active year for disposing of shares, totalling 14 transactions. Shawn Cross's most active month to dispose stocks was the month of November. 2021 saw Shawn Cross paying a total of $46,100.00 for 104,500 shares, this is the most they've acquired in one year. In 2021 Shawn Cross cashed out on 20,000 shares for a total of $301,193.19, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!